Thomas Grünberger

976 total citations
29 papers, 689 citations indexed

About

Thomas Grünberger is a scholar working on Hepatology, Oncology and Cancer Research. According to data from OpenAlex, Thomas Grünberger has authored 29 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Thomas Grünberger's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Thomas Grünberger is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease and Transplantation (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Thomas Grünberger collaborates with scholars based in Austria, Canada and United States. Thomas Grünberger's co-authors include Chaim M. Roifman, Ulrich Maier, Rudolf Steininger, R. Függer, Stephan Madersbacher, Nigel Sharfe, Ferdinand Mühlbacher, Andrew Freywald, Susanne Winkler and Michael Weber and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Thomas Grünberger

27 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Grünberger Austria 15 201 188 152 144 124 29 689
Sippie Huitema Netherlands 15 224 1.1× 57 0.3× 123 0.8× 315 2.2× 194 1.6× 24 977
Eiji Takai Japan 17 71 0.4× 209 1.1× 158 1.0× 225 1.6× 74 0.6× 36 843
Saioa Goñi Spain 16 137 0.7× 156 0.8× 116 0.8× 504 3.5× 109 0.9× 28 900
Claudia de Toma France 11 41 0.2× 99 0.5× 157 1.0× 255 1.8× 121 1.0× 18 1.2k
Takehiro Sando Japan 8 97 0.5× 275 1.5× 117 0.8× 343 2.4× 56 0.5× 13 932
Limin Zhai China 16 68 0.3× 140 0.7× 82 0.5× 448 3.1× 53 0.4× 33 763
Thomas Pusl Germany 16 275 1.4× 275 1.5× 300 2.0× 248 1.7× 60 0.5× 32 869
Huichuan Yu China 16 65 0.3× 392 2.1× 206 1.4× 272 1.9× 101 0.8× 61 880
Chen Huang China 16 133 0.7× 271 1.4× 146 1.0× 326 2.3× 150 1.2× 38 843

Countries citing papers authored by Thomas Grünberger

Since Specialization
Citations

This map shows the geographic impact of Thomas Grünberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Grünberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Grünberger more than expected).

Fields of papers citing papers by Thomas Grünberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Grünberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Grünberger. The network helps show where Thomas Grünberger may publish in the future.

Co-authorship network of co-authors of Thomas Grünberger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Grünberger. A scholar is included among the top collaborators of Thomas Grünberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Grünberger. Thomas Grünberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pilat, Nina, Thomas Grünberger, Martina Mittlböck, et al.. (2015). Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: A p53 Research Group study. European Journal of Surgical Oncology. 41(5). 683–689. 22 indexed citations
3.
Meshcheryakova, Anastasia, Dietmar Tamandl, Erika Bajna, et al.. (2014). B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer. PLoS ONE. 9(6). e99008–e99008. 84 indexed citations
4.
Scharitzer, Martina, Ahmed Ba‐Ssalamah, Helmut Ringl, et al.. (2013). Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. European Radiology. 23(8). 2187–2196. 81 indexed citations
5.
Zacherl, Maximilian, Gerwin A. Bernhardt, Johannes Zacherl, et al.. (2011). Surgery for liver metastases originating from sarcoma—case series. Langenbeck s Archives of Surgery. 396(7). 1083–1091. 5 indexed citations
6.
Tamandl, Dietmar, Beata Herberger, Peter Birner, et al.. (2011). Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases.. PubMed. 31(12). 4605–11. 12 indexed citations
7.
Starlinger, Patrick, et al.. (2010). Systemic effects of anti-VEGF therapy – Mini-review. European surgery. Supplement/European surgery. 42(1). 12–16. 1 indexed citations
8.
Scheithauer, Werner, Robert Pirker, Thomas Grünberger, & Gabriela Kornek. (2010). VEGF and EGFR inhibition: opening a new door to cancer treatment. European surgery. Supplement/European surgery. 42(1). 24–28.
9.
Sagmeister, Sandra, Annemarie Losert, Michael Grusch, et al.. (2008). HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis. Journal of Hepatology. 49(6). 955–964. 21 indexed citations
10.
Demin, Peter, et al.. (2004). Tyrenes: synthesis of new antiproliferative compounds with an extended conjugation. Bioorganic & Medicinal Chemistry. 12(11). 3019–3026. 12 indexed citations
11.
Freywald, Andrew, et al.. (2003). The EphB6 Receptor Inhibits JNK Activation in T Lymphocytes and Modulates T Cell Receptor-mediated Responses. Journal of Biological Chemistry. 278(12). 10150–10156. 63 indexed citations
12.
Grünberger, Thomas, Peter Demin, Nigel Sharfe, et al.. (2003). Inhibition of acute lymphoblastic and myeloid leukemias by a novel kinase inhibitor. Blood. 102(12). 4153–4158. 15 indexed citations
13.
Gnant, Michael, R. Roka, Daniela Kandioler, et al.. (2001). Different transendothelial migration behaviour pattern of blood monocytes derived from patients with benign and malignant diseases of the breast.. PubMed. 20(6B). 4599–604. 9 indexed citations
14.
Kandioler-Eckersberger, Daniela, Susanne Taucher, M. Rudas, et al.. (1998). P30 A different P53 genotype predicts major response to antracycline or paclitaxel based neoadjuvant therapy in breast cancer. European Journal of Cancer. 34. S21–S21. 3 indexed citations
15.
Maier, Ulrich, et al.. (1996). Late ureteral obstruction after kidney transplantation. Transplant International. 10(1). 65–68. 16 indexed citations
16.
Madersbacher, Stephan, et al.. (1996). The impact of liver transplantation on endocrine status in men. Clinical Endocrinology. 44(4). 461–466. 47 indexed citations
17.
Steininger, Rudolf, et al.. (1994). L-ARGININE DEFICIENCY AFTER LIVER TRANSPLANTATION AS AN EFFECT OF ARGINASE EFFLUX FROM THE GRAFT. Transplantation. 57(5). 665–668. 71 indexed citations
18.
Steininger, Rudolf, Erich Roth, R. Függer, et al.. (1994). Transhepatic metabolism of TNF-alpha, IL-6, and endotoxin in the early hepatic reperfusion period after human liver transplantation.. PubMed. 58(2). 179–83. 38 indexed citations
19.
20.
Kamel‐Reid, Suzanne, Michelle Letarte, Monica Doedens, et al.. (1991). Bone marrow from children in relapse with pre-B acute lymphoblastic leukemia proliferates and disseminates rapidly in scid mice. Blood. 78(11). 2973–2981. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sippie Huitema Breakdown of academic impact, for papers by Eiji Takai Breakdown of academic impact, for papers by Saioa Goñi Breakdown of academic impact, for papers by Claudia de Toma Breakdown of academic impact, for papers by Takehiro Sando Breakdown of academic impact, for papers by Limin Zhai Breakdown of academic impact, for papers by Thomas Pusl Breakdown of academic impact, for papers by Huichuan Yu Breakdown of academic impact, for papers by Chen Huang
Rankless by CCL
2026